CKDXF
Price:
$0.44
Market Cap:
$494.25M
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat w...[Read more]
Industry
Biotechnology
IPO Date
2011-10-25
Stock Exchange
OTC
Ticker
CKDXF
According to Opthea Limited’s latest financial reports and current stock price. The company's current ROE is 520.65%. This represents a change of 36.77% compared to the average of 380.66% of the last 4 quarters.
The mean historical ROE of Opthea Limited over the last ten years is 226.64%. The current 520.65% ROE has changed 129.73% with respect to the historical average. Over the past ten years (40 quarters), CKDXF's ROE was at its highest in in the June 2023 quarter at 1.10%. The ROE was at its lowest in in the June 2022 quarter at -166.36%.
Average
226.64%
Median
-29.57%
Minimum
-183.45%
Maximum
2.41%
Discovering the peaks and valleys of Opthea Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 443.81%
Maximum Annual ROE = 2.41%
Minimum Annual Increase = -1413.52%
Minimum Annual ROE = -183.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | 290.52% | -87.94% |
| 2023 | 2.41% | -1413.52% |
| 2022 | -183.45% | 443.81% |
| 2021 | -33.73% | 35.64% |
| 2020 | -24.87% | -62.99% |
| 2019 | -67.19% | 51.75% |
| 2018 | -44.28% | 289.61% |
| 2017 | -11.36% | -73.84% |
| 2016 | -43.45% | 70.97% |
| 2015 | -25.41% | -39.37% |
The current ROE of Opthea Limited (CKDXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
838.89%
5-year avg
491.61%
10-year avg
226.64%
Opthea Limited’s ROE is greater than Claritas Pharmaceuticals, Inc. (-436.27%), less than Inventiva S.A. (536.36%), greater than Oxurion N.V. (-17.00%), less than Columbia Care Inc. (42.28%), greater than TerrAscend Corp. (-70.88%), greater than Kindstar Globalgene Technology, Inc. (-3.68%), greater than SS Innovations International, Inc. (-50.44%), less than Adcock Ingram Holdings Limited (15.09%), greater than AnGes, Inc. (-369.09%), less than Dong Fang Hui Le Inc. (67.02%),
| Company | ROE | Market cap |
|---|---|---|
| -436.27% | $3.66K | |
| 536.36% | $618.13M | |
| -17.00% | $433.72M | |
| 42.28% | $521.35M | |
| -70.88% | $601.91M | |
| -3.68% | $675.13M | |
| -50.44% | $1.23B | |
| 15.09% | $624.32M | |
| -369.09% | $139.07M | |
| 67.02% | $400.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Opthea Limited's ROE?
How is the ROE calculated for Opthea Limited (CKDXF)?
What is the highest ROE for Opthea Limited (CKDXF)?
What is the 3-year average ROE for Opthea Limited (CKDXF)?
What is the 5-year average ROE for Opthea Limited (CKDXF)?
How does the current ROE for Opthea Limited (CKDXF) compare to its historical average?